Molecular & Cellular Toxicology

The Korean Society of Toxicogenomics and Toxicoproteomics (대한독성유전 단백체학회)
권호 표지

Gene Expression Changes in Peripheral Blood Mononuclear Cells from Cynomolgus Monkeys Following Astemizole Exposure

  • Park, Han-Jin (Toxicogenomics Team, Korea Institute of Toxicology) ;
  • Seo, Jeong-Wook (Devision of Non-clinical Studies, Korea Institute of Toxicology) ;
  • Oh, Jung-Hwa (Toxicogenomics Team, Korea Institute of Toxicology) ;
  • Lee, Sun-Hee (Toxicogenomics Team, Korea Institute of Toxicology) ;
  • Lee, Eun-Hee (Toxicogenomics Team, Korea Institute of Toxicology) ;
  • Kim, Choong-Yong (Devision of Non-clinical Studies, Korea Institute of Toxicology) ;
  • Yoon, Seok-Joo (Toxicogenomics Team, Korea Institute of Toxicology)
  • Published : 2008.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Surrogate tissue analysis incorporating -omics technologies has emerged as a potential alternative method for evaluating toxic effect of the tissues which are not accessible for sampling. Among the recent applications, blood including whole blood, peripheral blood lymphocytes and peripheral blood mononuclear cells (PBMCs) was suggested as a suitable surrogate tissue in determining toxicant exposure and effect at the pre- or early clinical stage. In this application, we investigated transcriptomic profiles in astemizole treated Cynomolgus monkey's PBMCs. PBMCs were isolated from 4-6 years old male monkeys at 24 hr after administration45 Helvetica Light (10 mg/kg, 30 mg/kg). Gene expression profiles of astemizole treated monkey's PBMCs were determined using Affymetrix $GeneChip^{(R)}$ Human Genome U133 plus 2.0 arrays. The expression levels of 724 probe sets were significantly altered in PBMCs at 10 or 30 mg/kg after astemizole administration following determination of paired t-test using statistical criteria of ${\geq}$$1.5-fold changes at P<0.05. Gene expression patterns in PBMCs showed a considerable difference between astemizole 10 and 30 mg/kg administration groups in spite of an administration of the same chemical. However, close examination using Ingenuity Pathway Analysis (IPA) software revealed that several gene sets related to cardiotoxicity were deregulated at astemizole 10 and 30 mg/kg administration groups. The deregulation of cardiac hypertrophy related genes such as TXN, GNAQ, and MAP3K5 was observed at 10 mg/kg group. In astemizole 30 mg/kg group, genes involved in cardiotoxicity including cardiac necrosis/cell death, dilation, fibrosis, and hypertrophy were also identified. These results suggest that toxicogenomic approach using PBMCs as surrogate tissues will contribute to assess toxicant exposures and identify biomarkers at the pre-clinical stage.

Keywords

References

  1. Nuwaysir, E. F., Bittner, M., Trent, J., Barrett, J. C. & Afshari, C. A. Microarrays and toxicology: the advent of toxicogenomics. Mol Carcinog 24:153-159 (1999) https://doi.org/10.1002/(SICI)1098-2744(199903)24:3<153::AID-MC1>3.0.CO;2-P
  2. Bartosiewicz, M., Penn, S. & Buckpitt, A. Applications of gene arrays in environmental toxicology: fingerprints of gene regulation associated with cadmium chloride, benzo(a)pyrene, and trichloroethylene. Environ Health Perspect 109:71-74 (2001) https://doi.org/10.2307/3434924
  3. Burczynski, M. E. et al. Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells. Toxicol Sci 58:399-415 (2000) https://doi.org/10.1093/toxsci/58.2.399
  4. Hamadeh, H. K. et al. Gene expression analysis reveals chemical-specific profiles. Toxicol Sci 67:219-231 (2002) https://doi.org/10.1093/toxsci/67.2.219
  5. Thomas, R. S. et al. Identification of toxicologically predictive gene sets using cDNA microarrays. Mol Pharmacol 60:1189-1194 (2001) https://doi.org/10.1124/mol.60.6.1189
  6. Hamadeh, H. K. et al. Methapyrilene toxicity: anchorage of pathologic observations to gene expression alterations. Toxicol Pathol 30:470-482 (2002) https://doi.org/10.1080/01926230290105712
  7. Waring, J. F., Ciurlionis, R., Jolly, R. A., Heindel, M. & Ulrich, R. G. Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol Lett 120:359-368 (2001) https://doi.org/10.1016/S0378-4274(01)00267-3
  8. Rockett, J. C. et al. DNA arrays to monitor gene expression in rat blood and uterus following 17beta-estradiol exposure: biomonitoring environmental effects using surrogate tissues. Toxicol Sci 69:49-59 (2002) https://doi.org/10.1093/toxsci/69.1.49
  9. Liew, C. C., Ma, J., Tang, H. C., Zheng, R. & Dempsey, A. A. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med 147:126-132 (2006) https://doi.org/10.1016/j.lab.2005.10.005
  10. Hoppu, K. et al. Accidental astemizole overdose in young children. Lancet 338:538-540 (1991) https://doi.org/10.1016/0140-6736(91)91101-Y
  11. Redfern, W. S. et al. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc Res 58:32-45 (2003) https://doi.org/10.1016/S0008-6363(02)00846-5
  12. Simons, F. E., Kesselman, M. S., Giddins, N. G., Pelech, A. N. & Simons, K. J. Astemizole-induced torsade de pointes. Lancet 2:624 (1988)
  13. Vorperian, V. R. et al. Torsade de pointes with an antihistamine metabolite: potassium channel blockade with desmethylastemizole. J Am Coll Cardiol 28:1556-1561 (1996) https://doi.org/10.1016/S0735-1097(96)00352-X
  14. Amundson, S. A. et al. Human in vivo radiation-induced biomarkers: gene expression changes in radiotherapy patients. Cancer Res 64:6368-6371 (2004) https://doi.org/10.1158/0008-5472.CAN-04-1883
  15. Forrest, M. S. et al. Discovery of novel biomarkers by microarray analysis of peripheral blood mononuclear cell gene expression in benzene-exposed workers. Environ Health Perspect 113:801-807 (2005) https://doi.org/10.1289/ehp.7635
  16. Wu, M. M., Chiou, H. Y., Ho, I. C., Chen, C. J. & Lee, T. C. Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects. Environ Health Perspect 111:1429-1438 (2003) https://doi.org/10.1289/ehp.6396
  17. Wang, Z. et al. Global gene expression profiling in whole-blood samples from individuals exposed to metal fumes. Environ Health Perspect 113:233-241 (2005) https://doi.org/10.1289/ehp.113-a233
  18. Mohr, S. & Liew, C. C. The peripheral-blood transcriptome: new insights into disease and risk assessment. Trends Mol Med 13:422-432 (2007) https://doi.org/10.1016/j.molmed.2007.08.003
  19. Debey, S. et al. Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types. Pharmacogenomics J 4:193-207 (2004) https://doi.org/10.1038/sj.tpj.6500240
  20. Bushel, P. R. et al. Blood gene expression signatures predict exposure levels. Proc Natl Acad Sci U S A 104:18211-18216 (2007)
  21. Paakkari, I. Cardiotoxicity of new antihistamines and cisapride. Toxicol Lett 127:279-284 (2002) https://doi.org/10.1016/S0378-4274(01)00510-0
  22. Yamamoto, M. et al. Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy. J Clin Invest 112:1395-1406 (2003) https://doi.org/10.1172/JCI200317700
  23. D'Angelo, D. D. et al. Transgenic Galphaq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci U S A 94:8121-8126 (1997)
  24. Wettschureck, N. et al. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes. Nat Med 7:1236-1240 (2001) https://doi.org/10.1038/nm1101-1236
  25. Yamashita, T. et al. Apoptosis signal-regulating kinase-1 is involved in vascular endothelial and cardiac remodeling caused by nitric oxide deficiency. Hypertension 50:519-524 (2007) https://doi.org/10.1161/HYPERTENSIONAHA.107.092049
  26. Tokudome, T. et al. Adrenomedullin inhibits doxorubicin-induced cultured rat cardiac myocyte apoptosis via a cAMP-dependent mechanism. Endocrinology 143:3515-3521 (2002) https://doi.org/10.1210/en.2002-220233
  27. Fukazawa, R. et al. Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt. J Mol Cell Cardiol 35:1473-1479 (2003) https://doi.org/10.1016/j.yjmcc.2003.09.012
  28. Kuramochi, Y. et al. Cardiac endothelial cells regulate reactive oxygen species-induced cardiomyocyte apoptosis through neuregulin-1beta/erbB4 signaling. J Biol Chem 279:51141-51147 (2004) https://doi.org/10.1074/jbc.M408662200
  29. Yasukawa, H. et al. Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways. J Clin Invest 108:1459-1467 (2001) https://doi.org/10.1172/JCI13939